This conference showcases emerging Southern California biotech and device companies and technologies seeking funding and partnerships

Agenda

September 16, 5:00 to 9:00 pm

SoCalBio Member Reception and Dinner
(By-Invitation-Only )

Abraxis Bioscience's Founder and Chairman, Dr. Patrick Soon-Shiong, Will Speak About Bio/Pharma Partnership Opportunities During the 11th SoCalBio Investor Conference

Dr. Soon-Shiong (photo right) will join a panel including Stephen de Laszlo, Ph.D., Director Scientific Liaison, Infectious Diseases, Merck, Hakan Sakul, Ph.D., Sr. Dir. & Gobal Head of Diagnostics, Molecular Medicine Group, Pfizer Global R&D, and Matt Busch, Director Finance Business Development, Amgen to discuss collaboration opportunities between emerging biotech firms and established pharma companies.

 

Organized by Conference lead sponsor, Ernst & Young, this panel is one of five breakout sessions offered during the conference on funding and partnering opportunities in this challenging economy. RSVP now to attend the conference

Dr. Nader has served as President and Chief Executive Officer of NPS Pharmaceuticals since March 2008. Before joining NPS, Dr. Nader was a venture partner at Care Capital, LLC and Chief Medical Officer of its Clinical Development Capital unit from July 2005, to June 2006. From 2000 to July 2005, he served as Senior Vice President, Integrated Healthcare Markets and Senior Vice-President, North America Medical and Regulatory Affairs with Aventis Pharmaceuticals. He also held similar positions at Hoechst Marion Roussel and served as Head of Global Commercial Operations at the Pasteur Vaccines division of Rhone-Poulenc. Francois Nader received a French State Doctorate in Medicine from St. Joseph University and a Physician Executive M.B.A. from the University of Tennessee... RSVP now to attend the conference

September 17, 7:00 am - 7:00 pm

• Ahmed Enany, President & CEO, Southern California Biomedical Council (SoCalBio)

• Julia Jun, Conference Co-Chair &  Partner, Ernst & Young

• Introduction by Michael Wise, Conference Co-Chair, Partner, Perkins Coie

• Presentation by Sasha Strauss, Managing Director, Innovation Protocol on “Branding Emerging Bioscience Companies to Attract Investors”

Track I: Drug Development  ( Arcadia C)

• Moderator:
  • Jonathan Lasch, Ph.D., Director, AMI - USC
• Presenting Companies:
  • CytomX
  •   iCo Therapeutics
  •  ImmunGene Inc
  •  Shenogen Pharma Group
  • APOImmune
  • Symthera

Track II: Medical Devices (Palisades Salon A & B)

• Moderator: 
  • Michael Sanders, Partner, Reed Smith
• Presenting Companies:
  • MiCardia 
  • Pulmostics 
  • Lerner Medical Devices
  • Dynacardia 
  • K-Space
  • Eye-Predict

Track III: IVD/Screening (Palisades Salon C & D) 

• Moderator: 
  • Mohammad Kondri, MPH, MBA, International Business Development Officer, Trade Commissioner, Life Sciences & Medical Technologies, Canadian Consulate General
• Presenting Companies:
  • DxTerity Diagnostics
  • ImaginAB
  • Med BioGene, Inc
  • Sofie Biosciences
  • preSage Biosciences, Inc.

Track I: Drug Development  (Arcadia C)

• Moderators:

  • Seth Levy, Partner, Davis Wright & Termaine

• Presenting Companies:

  • Western States Biopharmaceuticals

  • Ritter Pharmaceuticals

  • Ascalon

  • Kineta

  • Viral Genetics

Track II: Polymers, Drug Delivery and Regenerative Medicine ( Palisades Salon A & B)

• Moderators: 

  • Anthony Brill, Partner, Baker & Hostetler

• Presenting Companies: Polymers

  • Allvivo Vascular  

  • Fibron

• Presenting Companies: Drug Delivery

  • Biotic Labs

  • Replenish, Inc.

• Presenting Companies: Regenerative Medicine

  • Histogen

  • California Stem Cell, Inc.

Track III: Screening/Sensors ( Palisades Salon C & D)

• Moderators:

  • Robert Counter, Sr. Project Mgr, Healthcare, HDR

• Presenting Companies:

  • Applied Biocode, Inc

  • Ten Medical Systems

  • Inscent, Inc.

  • Solidus Biosciences

• Introduction by Stephen Williams, Ph.D., President & Chief Business Officer, Bench International

• Presentation by Francois Nader, M.D., President & CEO, NPS Pharmaceuticals
  “Fostering Innovation through Strategic Alliances in the Current Economy”

Review of VC Investment Trends in Biotechnology (Arcadia Ballroom)

• Moderator: 
  • Michael Wise, Partner, Perkins Coie
• Speakers: 
  • Christopher Fuglesang, Ph.D., Sr. Investment Professional, Tavistock Capital 
  • Frank Kung, Partner, Vivo Ventures 
  • Jay Shepard, Executive-in-Residence, Sofinnova Ventures

Forging Biotech/Pharma Partnerships (Palisades Salon A & B)

• Moderaors: 
  • Julia Jun, Partner, Ernst & Young 
  • Toni Gray, CEO, Cancer Innovations
• Speakers: 
  • Matt Busch, Director Finance Business Development, Amgen
  • Lawrence Cohn, Partner, Stradling Yocca Carlson & Rauth 
  • Stephen de Laszlo, PhD, Merck & Co., Director Scientific Liaison, Infectious Diseases Stephen joined Merck & Co 
  • Hakan Sakul, PhD, Senior Director Global Head of Diagnostics and Oncology Leads, Pfizer 
  • Patrick Soon-Shiong, Chairman, Abraxis Bioscience

What to Learn from Recent VC Investment in the Device Space (Palisades Salon C & D)

• Moderators:
  • Anthony Natale, M.D., Venture Partner, Prism VentureWorks  
• Speakers: 
  • Daniel Galles, Partner, HLM Venture Partners 
  • Marc Galletti, Managing Director, Longitude Capital 
  • Kirk Nielsen, Investment Professional, Versant Ventures 
  • Kathleen Tune, Principal, Thomas, McNerney & Partners

Accessing Government Grant Funding (Arcadia C)

• Moderator: 
  • Jared Jerotz, Sales, Data Protection, Iron Mountain 
• Speakers: 
  • Ali Andalibi, Ph.D., Program Director and head of the Therapeutics and Diagnostics Cluster, National Cancer Institute's SBIR Development Center, NIH 
  • David Hood, Senior Advisor, US Army Medical Command & President, DH3 & Associates
  • Gregory Milman, Ph.D., Director of the Office for Innovation and Special Programs, National Institute of Allergy and Infectious Diseases, NIH

Accessing Government Grant Funding … Continued (Arcadia C)

• Moderator:
  • Mark Benedict, Ph.D., Partner, Knobbe Martens 
• Introductory Presentation: 
  • Josué Villalta, Partner, Knobbe Martens: "Intellectual Property Issues Faced by Start-up Companies" 
• Entrepreneurial Perspectives on Designing Winning Grant Proposals: Panel Discussion 
  • Donavan Yeates, Ph.D., CEO, KAER Biotherapeutics 
  • David Rozzell, Ph.D., President & CEO, Solidus Biosciences 
  • Pamela Jackson, Director, Port Sys, SeQual Technologies

Forging Device Partnerships (Palisades Salon A & B)

• Moderators: 
  • Dennis Atkinson, Corporate Research Advancement Director, Office of the Vice Provost for Research Advancement, University of Southern California (USC) 
  • Robert Funsten, Partner, Bingham McCutchen 
• Speakers: 
  • Scott Boyer, Ph.D., Licensing Manager, Corporate Business Development, Beckman Coulter Inc. 
  • Rafael Carbunaru, Ph.D., Director of Emerging Indications R&D , Boston Scientific Neuromodulation
  • Monty Mars, Director of Business Development, Edwards Lifesciences 
  • Paul Musho, Business Development Manager, Research Sciences, GE Healthcare Life Sciences

Thanks to Conference Sponsors

Platinum
http://www.ey.com	http://www.perkinscoie.com
Gold
http://ami.usc.edu
Silver
http://www.bakerlaw.com	http://www.benchinternational. com
http://www.bingham.com	http://www. canadainternational.gc.ca/los_ angeles/index.aspx?lang=eng
http://www.dwt.com	http://www.hdrin c.com
http://www.ironmountain.com	http://www.kmob.com
http://www.reedsmith.com
Bronze
LCS Constructors http://www.lcslab.com/ Los Angeles/Orange County Biotechnology Center http://www.paccd.cc.ca.us/ biotech/ednet/home.html One Lambda Corporation http://www.onelambda.com Pharmaceutical Services Corporation http://www.biotech.com VWR http://www.vwr.com
Supporters
Aubrey Group BioReliance Bolton & Company California Technology Ventures Cannon Building Chubb City of Murrieta GXP Consultants Hong Kong Trade Development Council LA BioMed Spencer Stuart
Branding, Marketing and PR Partners:
Quantum Method http://www.quantummethod.com ExcelPR Group http://www.excelpr.com Business Wire http://www.businesswire.com